US Patent 11932851 Exon skipping compositions for treating muscular dystrophy
Patent 11932851 was granted and assigned to Sarepta Therapeutics on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11932851 Exon skipping compositions for treating muscular dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.